Dr. Falk Pharma Gmbh opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Dr. Falk Pharma Gmbh

Patent Number:
Title:
Corticosteroid Compositions
Opposition Date:
Sep 1, 2022
Patent Number:
Title:
Methods Of Treatment For Esophageal Inflammation
Opposition Date:
May 4, 2022
Patent Number:
Title:
Rapidly Dispersing Granules, Orally Disintegrating Tablets And Methods
Opposition Date:
Feb 23, 2021
Patent Number:
Title:
Compositions For The Treatment Of Gastrointestinal Inflammation
Opposition Date:
Sep 23, 2020
Patent Number:
Title:
Corticosteroid Containing Orally Disintegrating Tablet Compositions For Eosinophilic Esophagitis
Opposition Date:
Jul 22, 2020
Patent Number:
Title:
Orally Administered Corticosteroid Compositions
Opposition Date:
Apr 28, 2020
Patent Number:
Title:
Corticosteroid Compositions
Opposition Date:
Dec 19, 2019
Patent Number:
Title:
Orally Administered Corticosteroid Compositions
Opposition Date:
Mar 1, 2019
Patent Number:
Title:
Compositions For The Treatment Of Gastrointestinal Inflammation
Opposition Date:
Sep 27, 2018
Patent Number:
Title:
Compositions For The Treatment Of Inflammation Of The Gastrointestinal Tract
Opposition Date:
May 22, 2018

Latest patents of Dr. Falk Pharma Gmbh opposed by its competitors

Patent:
Grant Date:
Nov 2, 2022
Title:
Optimised Pharmaceutical Formula For The Treatment Of Inflammatory Changes Of The Esophagus
Oppositions:
1
Patent:
Grant Date:
Sep 26, 2018
Title:
Optimized Pharmaceutical Formulation For The Treatment Of Inflammatory Conditions Of The Esophagus
Oppositions:
1

Want to track Dr. Falk Pharma Gmbh?

Feel free to send us a message here and we will get back to you